EGFR and non-small cell lung carcinoma: Mutations of the gene EGFR are present on approximately 10–20% of patients with NSCLC, and in over 50% of patients with adenocarcinoma, which is the most frequent subtype among NSCLCs (45–55%) [5, 6].